Antimalarial Drug Development and New Targets

This publication has 48 references indexed in Scilit:

• Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects
  Parasitology Today, 2000
• A Genetic Map and Recombination Parameters of the Human Malaria Parasite Plasmodium falciparum
  Science, 1999
• Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy
  Molecular Microbiology, 1999
• An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery
  Pharmacology & Therapeutics, 1999
• Rational Drug Design Approach for Overcoming Drug Resistance: Application to Pyrimethamine Resistance in Malaria
  Journal of Medicinal Chemistry, 1998
• Yeast as a Model System to Study Drugs Effective against Apicomplexan Proteins
  Methods, 1997
• Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1997
• Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
  Molecular Microbiology, 1997
• Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase
  Proceedings of the National Academy of Sciences, 1997
• An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross
  Molecular and Biochemical Parasitology, 1992